LENZ Therapeutics’ $83.5 Million Series B Financing

Wilson Sonsini Goodrich & Rosati represented LENZ in the transaction.Biopharmaceutical company LENZ Therapeutics announced that it raised $83.5 million in an oversubscribed Series B financing. The…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now